Skip to Content


In some countries, this medicine may only be approved for veterinary use.



CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

α₂-Sympathomimetic agent

Chemical Name


Foreign Names

  • Romifidinum (Latin)
  • Romifidin (German)
  • Romifidine (French)
  • Romifidina (Spanish)

Generic Names

Brand Names

  • Sedivet [veterinary use]
    Boehringer Ingelheim Animal Health, Ireland; Boehringer Ingelheim Vetmedica, United Kingdom
  • Sedivet for Horses [veterinary use]
    Boehringer Ingelheim, Australia
  • Romidys [veterinary use]
    Virbac France, United Kingdom; Virbac S.A., Ireland
  • Sedivet [veterinary use]
    Boehringer, South Africa; Boehringer Ingelheim, Switzerland; Boehringer Ingelheim Animal, Netherlands; Boehringer Ingelheim Animal Health, Belgium; Boehringer Ingelheim Animals, New Zealand; Boehringer Ingelheim Santé Animale, France; Boehringer Ingelheim Vet, Italy; Boehringer Ingelheim Vet, Norway; Boehringer Ingelheim Vetmedica, Sweden; Boehringer Ingelheim Vetmedica, United States; Boehrvet BI-Vetmedica, Germany


BANBritish Approved Name
BANMBritish Approved Name (Modified)
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.